Back
Corporate News
Bacil Pharma confirms compliance with SEBI regulations for securities dematerialisation
12-Oct-2026, 03:54
Bacil Pharma Limited informed the BSE Limited that it has received a certificate from Bigshare Services Pvt. Ltd., confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the period ended September 30, 2026, pertaining to securities dematerialised and listed on stock exchanges.
